| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8776638 | The Breast | 2018 | 7 Pages |
Abstract
Hypofractionated VMAT-SIB in patients who had undergone adjuvant systemic therapy was safe and well tolerated in terms of acute and early late settings and cosmesis. Our data confirmed the results of other studies published on the association of hypofractionation and chemotherapy or concomitant boost.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Fiorenza De Rose, Antonella Fogliata, Davide Franceschini, Cristina Iftode, Pierina Navarria, Tiziana Comito, Ciro Franzese, Bethania Fernandes, Giovanna Masci, Rosalba Torrisi, Corrado Tinterri, Alberto Testori, Armando Santoro, Marta Scorsetti,